Found: 148
Select item for more details and to access through your institution.
Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 6, p. 1321, doi. 10.1093/jac/dks069
- By:
- Publication type:
- Article
Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs).
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 5, p. 1170, doi. 10.1093/jac/dks001
- By:
- Publication type:
- Article
Pre-clinical development of antifungal susceptibility test methods for the testing of the novel antifungal agent E1210 versus Candida: comparison of CLSI and European Committee on Antimicrobial Susceptibility Testing methods.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 11, p. 2581, doi. 10.1093/jac/dkr342
- By:
- Publication type:
- Article
Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006–09).
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 9, p. 2070, doi. 10.1093/jac/dkr239
- By:
- Publication type:
- Article
Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: report from the SENTRY antimicrobial surveillance programme (2007–09).
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 6, p. 1409, doi. 10.1093/jac/dkr081
- By:
- Publication type:
- Article
Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: results from an international surveillance study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. suppl_3, p. iii69, doi. 10.1093/jac/dkr101
- By:
- Publication type:
- Article
Comment on: Role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-β-lactamases.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. suppl_4, p. iv17, doi. 10.1093/jac/dkq252
- By:
- Publication type:
- Article
Telavancin activity against Gram-positive bacteria isolated from respiratory tract specimens of patients with nosocomial pneumonia.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 11, p. 2396, doi. 10.1093/jac/dkq335
- By:
- Publication type:
- Article
Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, Italy.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 11, p. 2329, doi. 10.1093/jac/dkq331
- By:
- Publication type:
- Article
Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008).
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 7, p. 1353, doi. 10.1093/jac/dkq094
- By:
- Publication type:
- Article
Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 64, n. 5, p. 1024, doi. 10.1093/jac/dkp319
- By:
- Publication type:
- Article
TR-700 in vitro activity against and resistance mutation frequencies among Gram-positive pathogens.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 63, n. 4, p. 716, doi. 10.1093/jac/dkp021
- By:
- Publication type:
- Article
Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infections.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 61, n. 5, p. 1092, doi. 10.1093/jac/dkn074
- By:
- Publication type:
- Article
Potential synergy activity of the novel ceragenin, CSA-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 61, n. 2, p. 365
- By:
- Publication type:
- Article
Comment on: Linezolid resistance in coagulase-negative staphylococci2.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2006, v. 58, n. 4, p. 899, doi. 10.1093/jac/dkl325
- By:
- Publication type:
- Article
Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003–2004).
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2006, v. 57, n. 5, p. 914, doi. 10.1093/jac/dkl093
- By:
- Publication type:
- Article
Oxazolidinone susceptibility patterns in 2004: report from the Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) Program assessing isolates from 16 nations.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2006, v. 57, n. 2, p. 279, doi. 10.1093/jac/dki437
- By:
- Publication type:
- Article
Evaluation of PPI-0903M (T91825), a novel cephalosporin: bactericidal activity, effects of modifying in vitro testing parameters and optimization of disc diffusion tests.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 56, n. 6, p. 1047, doi. 10.1093/jac/dki362
- By:
- Publication type:
- Article
Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovis.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 55, n. 4, p. 574, doi. 10.1093/jac/dki032
- By:
- Publication type:
- Article
Italian metallo--lactamases: a national problem? Report from the SENTRY Antimicrobial Surveillance Programme.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 55, n. 1, p. 61, doi. 10.1093/jac/dkh512
- By:
- Publication type:
- Article
Initial results from a longitudinal international surveillance programme for anidulafungin (2003).
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2004, v. 54, n. 6, p. 1051, doi. 10.1093/jac/dkh504
- By:
- Publication type:
- Article
Potential utility of a peptide deformylase inhibitor (NVP PDF-713) against oxazolidinone-resistant or streptogramin-resistant Gram-positive organism isolates.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2004, v. 53, n. 5, p. 804, doi. 10.1093/jac/dkh184
- By:
- Publication type:
- Article
Daptomycin activity and spectrum: a worldwide sample of 6737 clinical Gram-positive organisms.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2004, v. 53, n. 4, p. 669, doi. 10.1093/jac/dkh143
- By:
- Publication type:
- Article
Pseudomonas aeruginosa strains harbouring an unusual blaVIM-4 gene cassette isolated from hospitalized children in Poland (19982001).
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2004, v. 53, n. 3, p. 451, doi. 10.1093/jac/dkh095
- By:
- Publication type:
- Article
Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001).
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2004, v. 53, n. 2, p. 290, doi. 10.1093/jac/dkh039
- By:
- Publication type:
- Article
Multicentre evaluation of the in vitro activity of linezolid in the Western Pacific.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Comparative spectrum and activity of NVP-PDF386 (VRC4887), a new peptide deformylase inhibitor.
- Published in:
- 2003
- By:
- Publication type:
- journal article
In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococci.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Molecular characterization of SPM-1, a novel metallo-beta-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme.
- Published in:
- 2002
- By:
- Publication type:
- journal article
In vitro evaluation of AZD2563, a new oxazolidinone, tested against beta-haemolytic and viridans group streptococci.
- Published in:
- 2002
- By:
- Publication type:
- journal article
BMS284756 (formerly T-3811, a des-fluoroquinolone) potency and spectrum tested against over 10,000 bacterial bloodstream infection isolates from the SENTRY antimicrobial surveillance programme (2000).
- Published in:
- 2002
- By:
- Publication type:
- journal article
Pharmacodynamic considerations in the treatment of moderate to severe pseudomonal infections with cefepime.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Conventional dogma applied to quinolones? Time for a change.
- Published in:
- 2001
- By:
- Publication type:
- Letter
MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from the Americas: resistance implications in the treatment of serious infections.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2000, v. 46, p. 25, doi. 10.1093/jac/46.suppl_2.25
- By:
- Publication type:
- Article
Detection of emerging resistance patterns within longitudinal surveillance systems: data sensitivity and microbial susceptibility.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2000, v. 46, p. 1, doi. 10.1093/jac/46.suppl_2.1
- By:
- Publication type:
- Article
Anti-gonococcal activity of gemifloxacin against fluoroquinolone-resistant strains and a comparison of agar dilution and Etest methods.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998).
- Published in:
- 2000
- By:
- Publication type:
- journal article
Premafloxacin: a projected veterinary use fluoro-quinolone with significant activity against multi-resistant gram-positive human pathogens.
- Published in:
- 1996
- By:
- Publication type:
- Letter
Comparative in-vitro activity of quinupristin/dalfopristin (RP 59500) tested against penicillin-and macrolide-resistant pneumococci by the Etest.
- Published in:
- 1996
- By:
- Publication type:
- research
In-vitro activity of trovafloxacin (CP99,219) tested by two methods against 150 vancomycin-resistant enterococcal isolates.
- Published in:
- 1996
- By:
- Publication type:
- Letter
Cross-resistance analysis for clinafloxacin compared with ciprofloxacin, fleroxacin, ofloxacin, and sparfloxacin using a predictor panel of ciprofloxacin-resistant bacteria.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Evaluation of the in-vitro activity of furopenem (SY5555 or SUN5555) against respiratory tract pathogens and beta-lactamase producing bacteria.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Pulsed-field gel electrophoresis of restriction-digested genomic DNA and antimicrobial susceptibility of Xanthomonas maltophilia strains from Brazil, Switzerland and the USA.
- Published in:
- 1994
- By:
- Publication type:
- journal article
In-vitro activity of FK-037, a new parenteral cephalosporin.
- Published in:
- 1994
- By:
- Publication type:
- journal article
In-vitro comparison of DU-6859a, a novel fluoroquinolone, with other quinolones and oral cephalosporins tested against 5086 recent clinical isolates.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Old In Vitro Antimicrobial Breakpoints Are Misleading Stewardship Efforts, Delaying Adoption of Innovative Therapies, and Harming Patients.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 7, p. 1, doi. 10.1093/ofid/ofaa084
- By:
- Publication type:
- Article
1591. Updated Fluoroquinolone MIC Breakpoints: Impact on Susceptibility Rates in the United States.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S580, doi. 10.1093/ofid/ofz360.1455
- By:
- Publication type:
- Article
1590. Updated Aminoglycoside (AG) MIC Breakpoints (BP) to Minimize Adverse Events and Improve Outcome: Impact on Susceptibility (S) Rates.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S580, doi. 10.1093/ofid/ofz360.1454
- By:
- Publication type:
- Article
1534. Polymyxin Antimicrobial Susceptibility (AST) Testing and Breakpoints for P. aeruginosa, A. baumannii, and Enterobacteriaceae: Recommendations from the United States Committee on Antimicrobial Susceptibility Testing (USCAST).
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S559, doi. 10.1093/ofid/ofz360.1398
- By:
- Publication type:
- Article